Gender | Prostate carcinoma TNM clinical staging | Prostatectomy Scheduled
Item
men newly diagnosed with prostate cancer who are scheduled for prostatectomy (stage t1 or t2)
boolean
C0079399 (UMLS CUI [1])
C0600139 (UMLS CUI [2,1])
C3258246 (UMLS CUI [2,2])
C0033573 (UMLS CUI [3,1])
C0205539 (UMLS CUI [3,2])
Body mass index
Item
body mass index (bmi) 25-45 kg/m2
boolean
C1305855 (UMLS CUI [1])
Access Internet
Item
have internet access
boolean
C0444454 (UMLS CUI [1,1])
C0282111 (UMLS CUI [1,2])
Availability of Smartphone
Item
have an ipad/iphone/idevice
boolean
C0470187 (UMLS CUI [1,1])
C3204335 (UMLS CUI [1,2])
5-alpha Reductase Inhibitors
Item
history of 5 alpha reductase inhibitors prior 3 months
boolean
C2936788 (UMLS CUI [1])
Therapeutic radiology procedure
Item
history of radiation therapy
boolean
C1522449 (UMLS CUI [1])
Cancer treatment
Item
taking active cancer treatment
boolean
C0920425 (UMLS CUI [1])
Salvage Therapy
Item
undergoing salvage therapy
boolean
C0085405 (UMLS CUI [1])
Hormone refractory prostate cancer
Item
castration-resistant prostate cancer
boolean
C1328504 (UMLS CUI [1])
Neoplasm Metastasis
Item
evidence of metastasis
boolean
C0027627 (UMLS CUI [1])
Biochemical recurrence
Item
evidence of biochemical recurrence
boolean
C2985506 (UMLS CUI [1])
High risk Medical condition | Gout | Kidney Disease
Item
high risk medical condition (e.g. gout or kidney disease)
boolean
C4319571 (UMLS CUI [1,1])
C3843040 (UMLS CUI [1,2])
C0018099 (UMLS CUI [2])
C0022658 (UMLS CUI [3])